Akt Phosphorylation Orchestrates T11TS Mediated Cell Cycle Arrest in Glioma Cells-Reference-Cited by-同舟云学术

Akt Phosphorylation Orchestrates T11TS Mediated Cell Cycle Arrest in Glioma Cells

Published:2021-10-11 Issue:10 Volume:39 Page:854-870
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Acharya Sagar¹,Chatterjee Sirshendu²,Chaudhuri Suhnrita³,Singh Manoj Kumar⁴,Bhattacharya Debanjan⁵,Bhattacharjee Malabika⁶,Ghosh Anirban⁷^ORCID,Chaudhuri Swapna⁴⁸

Affiliation:

1. Department of Zoology, Vidyasagar University, Paschim Medinipur, Midnapore, India

2. Department of Biotechnology, Techno India University, Kolkata, India

3. 4D Pharma Research Ltd, Life, Aberdeen, UK

4. Department of Laboratory Medicine, School of Tropical Medicine, Kolkata, India

5. Department of Neurology and Rehabilitation Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH, USA

6. Department of Zoology, Thakurpukur Vivekananda College, Kolkata, India

7. Department of Zoology, Netaji Subhas Open University, Kolkata, India

8. Chittaranjan National Cancer Institute, Kolkata, India

Funder

Council of Scientific and Industrial Research (CSIR), Govt. of India.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2021.1986060

Reference60 articles.

1. Immunotherapeutic Strategies for Malignant Glioma

2. MOLECULAR PATHOLOGY OF MALIGNANT GLIOMAS

3. Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications

4. Overview of current immunotherapeutic strategies for glioma

5. Induction of G1 arrest in glioma cells by T11TS is associated with upregulation of Cip1/Kip1 and concurrent downregulation of cyclin D (1 and 3)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mechanism of BUD13 m6A methylation mediated MBNL1-phosphorylation by CDK12 regulating the vasculogenic mimicry in glioblastoma cells;Cell Death & Disease;2022-12-03

2. Therapeutic intervention of glioma with the novel antineoplastic agent T11TS: the story so far;Immunotherapy;2022-10